Vometa oral suspension
Ingredients in every 5 ml
Each package contains
|ATC Level 1||A - Alimentary tract and metabolism|
|ATC Level 2||A03 - Drugs for Functional Gastrointestinal Disorders|
|ATC Level 3||A03F - Propulsives|
18 YEARS OLD AND ABOVE
The dose should be the lowest effective dose for the individual situation (typically 30 mg/day) and the dose may be increased, to a maximum daily oral dose of 40 mg/day.
Chronic dyspepsia: 10 mg, 3 times daily, 15-30 minutes before meals and before bedtime.
Nausea and vomiting: 10 mg, 3-4 times daily before meals and before bedtime.
0 TO 18 YEARS OLD
Children (nausea and vomiting related to chemotherapy and radiotherapy): 2.5 ml per 10 kg body weight, 3-4 times daily before meals and before bedtime.
Use in infants/pediatric
Although neurological adverse reactions are rare, the risk of neurological adverse reaction is higher in young children since metabolic functions and the blood-brain barrier are not fully developed in the first months of life. Therefore, it is recommended that the dose should be determined accurately and followed strictly in neonates, infants and children. Overdosing may cause extrapyramidal symptoms in children, but other causes should be taken into consideration.
Use in patient with renal impairment
Since very little unchanged drug is excreted via the kidneys, dose modification in patients with renal insufficiency is not needed. Therefore, on repeated administration, the dosing frequency of domperidone should be reduced to once or twice daily depending on the severity of the impairment, and the dose may need to be reduced. Such patients on prolonged therapy should be reviewed regularly.
– Symptomatic treatment of the dyspeptic syndrome that may be associated with delayed gastric emptying, gastroesophageal reflux and esophagitis.
– Epigastric sense of fullness, feeling of fullness abdominal distension
– Bloating, burping
– Nausea and vomiting
– Heartburn with or without regurgitation of stomach contents to mouth
– Nausea, vomiting, burping due to various causes:
– Gastrointestinal intolerance due to anti-cancer chemotherapy, digitalis, levodopa and others including radiotherapy.
– Abdominal organs, gastrointestinal hepatobiliary, peritoneal and renal pathology.
– VOMETA is not recommended for pediatrics unless to prevent nausea and vomiting associated with chemotherapy or cancer radiotherapy.